Mitra Zamani1 , Asghar Heidarian2 , Mohammad Sadegh Mirdehghan3
Unknown Affiliation

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

Two-Years Corneal Collagen Cross-Linking Outcomes in Patients with Keratoconus Mitra Zamani1 , Asghar Heidarian2 , Mohammad Sadegh Mirdehghan3
Indian Journal of Forensic Medicine & Toxicology Vol. 14 No. 3 (2020): Indian Journal of Forensic Medicine & Toxicology
Publisher : Institute of Medico-legal Publications Pvt Ltd

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37506/ijfmt.v14i3.10724

Abstract

Aims: This study aimed to report refractive, topographic, and tomographic outcomes of 2-years corneal collagen cross-linking in patients with progressive keratoconus. Materials and Method: This prospective study was conducted on76 eyes of 40 patients with progressive keratoconus and a corneal thickness of at least 400?m. After the baseline examination, cross-linking was performed using riboflavin 0.1% and ultraviolet irradiation (370 nm, 3 mW/cm2) for 30 min. Uncorrected visual acuity (UCVA), best spectacle-corrected visual acuity (BSCVA), manifest refraction spherical equivalent (MRSE), cylinder, keratometric readings, and corneal thickness were evaluated at baseline, 6, 12, and 24 months after corneal collagen cross-linking. Results: Results showed that at a 24-month follow-up, mean BSCVA, and UCVA had significant improvements. Changes in MRSE and cylinder were not significant during the two years of follow-up. At a 2-years follow-up, the mean values of minimum keratometry, maximum keratometry, and average keratometry decreased significantly to0.75, 0.97, and 0.52 D, respectively, compared to their baseline values. Anterior best fit sphere (BFS) also had significant difference at 24-month follow-up compared to base line evaluation. The central corneal thickness decreased significantly up to38 ? after 2 years. Conclusion: Corneal collagen cross-linking is an effective treatment to stop the progression of keratoconusas shown by reduced keratometry and improved vision.